author

 
 

Meta

Julie Steenhuysen
Japan Times
WORLD / Science & Health / FOCUS
Aug 31, 2020
Scientists see downsides to top COVID-19 vaccines from Russia and China
High-profile COVID-19 vaccines developed in Russia and China share a potential shortcoming: They are based on a common cold virus that many people have been exposed to, potentially limiting their effectiveness, some experts say.
Japan Times
BUSINESS / Companies / FOCUS
Feb 3, 2019
Bypassing U.S. regulators, Takeda takes its dengue shot to the tropics first
A new vaccine for the dengue virus is taking a potentially risky road to prevent the mosquito-borne disease that infects nearly 400 million people each year.
Japan Times
BUSINESS / Companies
Dec 1, 2016
Takeda drug could be part of functional cure for HIV: study
Dr. Anthony Fauci doesn't get too excited about the results of animal studies, and he doesn't make house calls.
Japan Times
WORLD / Science & Health
May 14, 2015
How DNA sequencing is transforming the hunt for new drugs
Drug manufacturers have begun amassing enormous troves of human DNA in hopes of significantly shortening the time it takes to identify new drug candidates, a move some say is transforming the development of medicines.
Japan Times
WORLD / Science & Health
Dec 22, 2014
Cure sought in the blood of Ebola survivors
For months, Vanderbilt University researcher Dr. James Crowe has been desperately seeking access to the blood of U.S. Ebola survivors, hoping to extract the proteins that helped them overcome the deadly virus for use in new, potent drugs.
Japan Times
WORLD / Science & Health
Aug 3, 2014
FDA ready to work with firms on Ebola drugs
The worst Ebola outbreak in history is heaping new pressure on U.S. regulators to speed the development of treatments for the deadly virus, which has killed more than 700 people since February.
Japan Times
WORLD / Science & Health / FOCUS
Jun 20, 2014
Insurers balk at cost as gene tests unlock medical mysteries
Aimee Robeson just wants an answer.

Longform

Mount Fuji is considered one of Japan's most iconic symbols and is a major draw for tourists. It's still a mountain, though, and potential hikers need to properly prepare for any climb.
What it takes to save lives on Mount Fuji